Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1150271-53-6 | MDL No. : | MFCD09998360 |
Formula : | C20H26BNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 323.24 | Pubchem ID : | - |
Synonyms : |
|
Num. heavy atoms : | 24 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 99.98 |
TPSA : | 30.49 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.6 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 3.77 |
Log Po/w (WLOGP) : | 2.97 |
Log Po/w (MLOGP) : | 2.59 |
Log Po/w (SILICOS-IT) : | 3.42 |
Consensus Log Po/w : | 2.55 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.26 |
Solubility : | 0.0178 mg/ml ; 0.0000551 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.1 |
Solubility : | 0.0255 mg/ml ; 0.0000788 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -7.35 |
Solubility : | 0.0000144 mg/ml ; 0.0000000445 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.31 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501 | UN#: | |
Hazard Statements: | H302-H312-H332 | Packing Group: | |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
63 mg | With tetrakis(triphenylphosphine) palladium(0); potassium carbonate In 1,4-dioxane; water at 110℃; | 365 Example 365 N-[1-(5-{2-[(benzylamino)methyl]phenyl}thiophen-2-yl)ethyl]-6,7-dimethoxy-2- methylquinazolin-4-amine A mixture of N-[1 -(5-bromothiophen-2-yl)ethyl]-6,7-dimethoxy-2-methylquinazolin-4-amine (prepared as described in example 209; 100 mg, 0.24 mmol), 2-(N- benzylaminomethyl)phenylboronic acid, pinacol ester (commercially available; 80.8 mg, 0.24 mmol), potassium carbonate (135.4 mg, 0.98 mmol) and tetrakis(triphenylphosphin) palladium(O) (28.3 mg, 0.025 mmol) in dioxane (2.5 mL) and water (0.5 mL) was stirred at 1 10°C overnight. The reaction mixture was evaporated and the crude product was purified via HPLC to yield 48% of the title compound (63 mg). 1H-NMR (400 MHz, DMSO-de): δ [ppm] = 8.14 (d, 1H), 7.65 (s, 1H), 7.54 (d, 1H), 7.34-7.22 (m, 7H), 7.22-7.14 (m, 1H), 7.1 1 (d, 1H), 7.06-7.03 (m, 2H), 5.96 (t, 1H), 3.86 (d, 6H), 3.73-3.61 (m, 4H), 2.54-2.52 (m, 1H), 2.44-2.40 (m, 3H), 1.71 (d, 3H). LC-MS (method 7): m/z: [M+H]+ = 525.2, Rt = 0.66 min. |
[ 1012785-46-4 ]
Diethyl({[2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl})amine
Similarity: 1.00
[ 1218791-16-2 ]
N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)ethanamine
Similarity: 1.00
[ 1218791-16-2 ]
N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)ethanamine
Similarity: 1.00
[ 129636-11-9 ]
N,N-Dimethyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
Similarity: 0.98
[ 1150271-47-8 ]
N-Methyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
Similarity: 0.98
[ 1012785-46-4 ]
Diethyl({[2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl})amine
Similarity: 1.00
[ 1218791-16-2 ]
N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)ethanamine
Similarity: 1.00
[ 129636-11-9 ]
N,N-Dimethyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
Similarity: 0.98
[ 1150271-47-8 ]
N-Methyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
Similarity: 0.98
[ 934586-48-8 ]
N-Methyl-N-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)propan-2-amine
Similarity: 0.97
[ 1012785-46-4 ]
Diethyl({[2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl})amine
Similarity: 1.00
[ 1218791-16-2 ]
N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)ethanamine
Similarity: 1.00
[ 129636-11-9 ]
N,N-Dimethyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
Similarity: 0.98
[ 1150271-47-8 ]
N-Methyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
Similarity: 0.98
[ 1012785-46-4 ]
Diethyl({[2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl})amine
Similarity: 1.00
[ 1218791-16-2 ]
N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)ethanamine
Similarity: 1.00
[ 129636-11-9 ]
N,N-Dimethyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
Similarity: 0.98
[ 1150271-47-8 ]
N-Methyl-1-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
Similarity: 0.98
[ 934586-48-8 ]
N-Methyl-N-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)propan-2-amine
Similarity: 0.97